Emtricitabine / Tenofovir

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 17 USDMF, 2 JDMF, 14 EU WC, 6 KDMF, 19 NDC API, 16 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

28 Drugs in Development

28 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

171 FDF Dossiers, 52 FDA Orange Book, 32 Europe, 24 Canada, 52 South Africa, 11 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG, TABLET;ORAL - 150MG;150MG;200MG;300MG, TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE, TABLET;ORAL - 120MG;EQ 15MG BASE, TABLET;ORAL - 200MG;EQ 25MG BASE, TABLET;ORAL - 200MG;EQ 25MG BASE;EQ 25MG BASE, TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE, TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE, CAPSULE;ORAL - 200MG, TABLET;ORAL - 100MG;150MG, TABLET;ORAL - 133MG;200MG, TABLET;ORAL - 167MG;250MG, TABLET;ORAL - 200MG;300MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 4 SPI Pharma, 2 Seqens, 8 DKSH, 1 Jai Radhe Sales, 6 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 12 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 26 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 2 Finar, 8 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 16 Roquette, 9 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

70 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 33 Controlled & Modified Release, 31 Direct Compression, 24 Thickeners and Stabilizers, 22 Disintegrants & Superdisintegrants, 22 Granulation, 18 Solubilizers, 16 Topical, 16 Lubricants & Glidants, 14 Co-Processed Excipients, 12 Film Formers & Plasticizers, 11 Taste Masking, 11 Parenteral, 9 Empty Capsules, 7 Chewable & Orodispersible Aids, 6 Emulsifying Agents, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 3 Rheology Modifiers

DIGITAL CONTENT

6 DATA COMPILATION #PharmaFlow, 3 STOCK RECAP #PipelineProspector, 191 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 29 Finished Drug Prices, 55 Annual Reports

MARKET PLACE

8 APIs, 9 FDF Dossiers

PATENTS & EXCLUSIVITIES

111 US Patents, 11 US Exclusivities, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 USP, 4 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 210251 / DOSAGE - TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
BICTEGRAVIR SODIUM(UNII: 4L5MP1Y7W7) (BICTEGRAVIR - UNII:8GB79LOJ07)	BICTEGRAVIR	30mg \| 50mg
EMTRICITABINE(UNII: G70B4ETF4S) (EMTRICITABINE - UNII:G70B4ETF4S)	EMTRICITABINE	120mg \| 200mg
TENOFOVIR ALAFENAMIDE FUMARATE(UNII: FWF6Q91TZO) (TENOFOVIR ANHYDROUS - UNII:W4HFE001U5)	TENOFOVIR ANHYDROUS	15mg \| 25mg

Inactive Ingredients

Ingredient Name	Gilead Sciences, Inc.
CROSCARMELLOSE SODIUM(M28OL1HH48)
FERRIC OXIDE RED(1K09F3G675)
FERROSOFERRIC OXIDE(XM0M87F357)
MAGNESIUM STEARATE(70097M6I30)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990)
TALC(7SEV7J4R1U)
TITANIUM DIOXIDE(15FIX9V2JP)
WATER(059QF0KO0R)

Drug Product Composition: Emtricitabine / Tenofovir